4-N-Acyl, 2'-N-acyl and 4,2'-N,N'-diacylfortimicin E derivatives

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 17R, 536 4, A61K 3171, C07H 1522

Patent

active

041839200

ABSTRACT:
4-N-Acyl, 2'-N-acyl and 4,2' -N,N' -diacylfortimicin E derivatives represented by the formula ##STR1## wherein R is hydrogen, acyl, aminoacyl, N-lower alkylamino acyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue; R.sub.1 is hydrogen, acyl, aminoacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue, with the limitation that R cannot be hydrogen when R.sub.1 is hydrogen, and R.sub.1 cannot be hydrogen when R is hydrogen; the pharmaceutically acceptable salts thereof; intermediates therefor; pharmaceutical compositions; and methods of making and using the compounds. The compounds are useful as antibiotics.

REFERENCES:
patent: 3931400 (1976-01-01), Nara et al.
patent: 3976768 (1976-08-01), Nara et al.
patent: 3985727 (1976-10-01), Daniels

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-N-Acyl, 2'-N-acyl and 4,2'-N,N'-diacylfortimicin E derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-N-Acyl, 2'-N-acyl and 4,2'-N,N'-diacylfortimicin E derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-N-Acyl, 2'-N-acyl and 4,2'-N,N'-diacylfortimicin E derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1028364

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.